Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Anthera Pharmaceuticals Inc (NASDAQ:ANTH)

6.93
Delayed Data
As of Sep 03
 -0.48 / -6.48%
Today’s Change
1.46
Today|||52-Week Range
11.65
+338.61%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization80.0K331.0K353.0K344.0K
 
 
 
 
 
 
Operating ExpensesGross Income-80.0K-331.0K-353.0K-344.0K
 
 
 
 
 
General Expenses93.1M55.6M27.9M28.1M
 
 
 
 
 
Research And Development85.3M49.2M21.7M21.8M
 
 
 
 
 
Total Operating Expenses93.1M55.9M28.2M28.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-93.1M-55.9M-28.2M-28.5M
 
 
 
 
 
Interest Expense On Debt2.8M3.4M2.6M1.0M
 
 
 
 
 
Other Expenses606.0K-111.0K-15.0K-96.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-95.3M-59.4M-30.9M-29.6M
 
 
 
 
 
Net Income-95.3M-59.4M-30.9M-29.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS4.7M7.2M18.3M21.8M
 
 
 
 
 
Shares To Calculate EPS Diluted4.7M7.2M18.3M21.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$20.40-$8.24-$1.69-$1.36
 
 
 
 
 
EPS Diluted-$20.40-$8.24-$1.69-$1.36